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ABSTRACT  
 
Maintaining the integrity of the mitotic spindle in metaphase is essential to ensure 
normal cell division. We show here that depletion of microtubule-associated protein 
ATIP3 reduces metaphase spindle length. Mass spectrometry analyses identified 
the microtubule minus-end depolymerizing kinesin Kif2A as an ATIP3 binding 
protein. We show that ATIP3 controls metaphase spindle length by interacting with 
Kif2A and its partner Dda3 in an Aurora kinase A-dependent manner. In the absence 
of ATIP3, Kif2A and Dda3 accumulate at spindle poles, which is consistent with 
reduced poleward microtubule flux and shortening of the spindle. ATIP3 silencing 
also limits Aurora A localization to the poles. Transfection of GFP-Aurora A, but not 
kinase-dead mutant, rescues the phenotype, indicating that ATIP3 maintains Aurora 
A activity on the poles to control Kif2A targeting and spindle size. Collectively, these 
data emphasize the pivotal role of Aurora kinase A and its mutual regulation with 
ATIP3 in controlling spindle length. 
 
 
 
 
Keywords : ATIP3, Kif2A, Dda3, Aurora A, mitotic kinase, mitotic spindle, poleward 
microtubule flux 
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INTRODUCTION 
 
The size of the mitotic spindle in metaphase varies among different cell types and 
species but remains constant for a given cell type, despite high dynamics of spindle 
microtubules [1–3]. The spindle in metaphase must reach an optimal size to capture 
and bi-orient all duplicated chromosomes prior to cell division, and to allow 
separation of the asters beyond a minimal distance for proper cleavage by the 
cytokinesis machinery at late stages of cell division [3]. Defects in spindle size and 
architecture can lead to mitotic defects and promote aneuploidy, which is a hallmark 
of cancer. Metaphase spindle length is controlled by intrinsic and extrinsic factors 
[3]. Poleward microtubule flux, which consists of translocation of tubulin 
heterodimers towards the poles, coupled to a balance between polymerization of 
microtubule plus ends at kinetochores and depolymerization of minus ends at the 
poles [4, 5], is a major mechanism to maintain the spindle at a constant length in 
metaphase [2, 6]. Microtubule-associated proteins and depolymerizing kinesins, 
that regulate microtubule dynamics at both ends, thus appear as important 
regulators of poleward flux and spindle length [3, 7–9].  
The Kif2A kinesin is a key regulator of poleward microtubule flux and spindle size in 
drosophila, xenopus and human cells [6, 10–13]. Kif2A belongs to the kinesin-13 
family of depolymerizing kinesins also including Kif2B and MCAK/Kif2C [14]. During 
mitosis, Kif2A localizes to spindle poles where it depolymerizes microtubule minus 
ends [10, 15, 16], thereby controlling the rate of poleward microtubule flux. Transport 
of Kif2A to spindle poles is ensured by minus-end-directed motor protein 
dynein/dynactin [10] and is increased by interaction with microtubule-associated 
Dda3 protein, whose expression and phosphorylation are markedly elevated in 
mitosis [17, 18]. Depletion of either Dda3 or Kif2A increases mitotic spindle size [10, 
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17]. The microtubule depolymerizing activity of Kif2A and its recruitment to the poles 
are inhibited by Aurora kinase A (Aurora A) [19], a major mitotic kinase that localizes 
on spindle poles. Aurora A fulfills numerous functions [20, 21] including the 
regulation of spindle size [13, 22]. However, the mechanisms by which this kinase 
controls metaphase spindle length are poorly defined. Whether maintaining correct 
spindle size in metaphase depends on Aurora A-mediated regulation of Kif2A 
recruitment to the poles remains to be investigated.  
ATIP3 is a microtubule-associated protein that decorates the centrosome and 
microtubule cytoskeleton in interphase, and the mitotic spindle and spindle poles 
during mitosis [23]. Previous studies have shown that ATIP3 is a potent microtubule 
stabilizer [24] that reduces microtubule dynamics by interacting with End-Binding 
protein EB1 in interphase [25, 26]. ATIP3 is the product of candidate tumor 
suppressor gene MTUS1 whose expression is markedly down-regulated in 
aggressive breast tumors [23, 24]. We have recently shown that ATIP3 depletion is 
associated with increased aneuploidy and mitotic defects [27]. 
In this study, we show that ATIP3 depletion leads to shortening of the metaphase 
spindle. Mass spectrometry analysis identified Kif2A as an intracellular partner of 
ATIP3. We provide evidence that ATIP3 forms a complex with Kif2A and Dda3 and 
limits their recruitment to the poles, thereby contributing to maintaining constant 
spindle size in metaphase. The interaction between ATIP3, Dda3 and Kif2A is 
increased in mitosis and requires phosphorylation by Aurora kinase A. Conversely, 
the localization of Aurora A at spindle poles is regulated by ATIP3. Overall, we show 
that reciprocal regulation of ATIP3 and Aurora kinase A during mitosis ensures the 
timely assembly of a molecular ATIP3-Dda3-Kif2A complex that controls metaphase 
spindle length.   
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MATERIALS AND METHODS 
 
Cell lines and synchronization 
Human cancer cell lines MCF-7, MCF-7 cells stably expressing moderate levels of 
GFP-ATIP3 (HC6 clone), HCC1143 and HeLa were described previously [23, 24]. 
MCF-7 cells express undetectable levels of ATIP3 whereas HCC1143 and HeLa 
cells express endogenous ATIP3 [23, 24]. MCF-7 cells were cultured in DMEM-F12 
supplemented with 5% bovine calf serum. HCC1143 cells were cultured in RMPI 
supplemented with 10% bovine calf serum and 1% sodium pyruvate. HeLa cells 
were cultured in DMEM supplemented with 10% bovine calf serum, 100 U/ml 
penicillin, and 100 U/ml streptomycin (all from Gibco) at 37°C and 5% CO2. Cells 
were routinely authenticated by morphologic observation and tested for absence of 
mycoplasma contamination using Venor® GeM Advance Kit (MB Minerva 
biolabs®). 
For synchronization in metaphase, MCF-7 and HCC1143 cells were treated with 50 
ng/ml nocodazole for 16h and released for 45 minutes. 
 
Plasmid constructs, siRNAs and transfections 
Plasmids encoding GFP-ATIP3, GFP-D1, GFP-D2, GFP-D2, GFP-D2N, GFP-D2C, 
GFP-D3, GFP-ATIP3delCN and GFP-D2delCN were described elsewhere [24, 25]. 
Deletion mutants GFP-delCN2 and GFP-D2delCN2 (lacking amino acid positions 
635 to 816 of ATIP3, accession number NP_001001924) were obtained by PCR 
amplification of the ATIP3 and D2 sequence, respectively, using the following 
oligonucleotides: 5’- GGG TCC GTT TCT GCG TTG TTT TCT GGT AAT GCC GCT 
GTC -3’ and 5’- GAC AGC GGC ATT ACC AGA AAA CAA CGC AGA AAC GGA 
CCC -3’ and QuikChange® II XL Site-Directed and Mutagenesis Kit (Agilent). 
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Plasmids encoding GFP-AurA and GFP-AurA-KD were described elsewhere [28–
30]. Plasmid encoding Kif2A-GFP was provided by Jamel Chelly (Institut de 
Génétique et de Biologie Moléculaire et Cellulaire, Strasbourg, France). All cDNA 
constructs were transfected (2 to 4µg) for 24h using X- treme Gene 9 (Roche) or 
Lipofectamine 2000 (Invitrogen). 
Specific and control scrambled siRNAs were from Dharmacon (ThermoFisher 
Scientific). The following sequences were used: ATIP3#1, 5’- 
UGGCAGAGGUUUAAG GUUA-3’; ATIP3#2, 5’-GCAAAUAGCUGCUCCAAAA-3’; 
Kif2A, 5’-GGCAAAGAGAUUG ACCUGG-3’; Aurora A, 5’- 
AUGCCCUGUCUUACUGUCA-3’; Dda3, 5’-AAGCAAGACU UCAGUAGCAUU-3’. 
For rescue experiments of ATIP3 knock-down, HeLa cells were transfected with 
ATIP3#1 siRNA that targets the 5’ untranslated sequence of ATIP3 and allows 
ectopic expression of the ATIP3 coding sequence [25]. 
All siRNAs (50 nM) were transfected for 48h to 72h using Lipofectamine 2000 
(Invitrogen) and silencing efficiency was evaluated by immunoblotting. Antibodies 
used for immunoblotting were rabbit anti-ATIP3 (anti-MTUS1; ARP44419-P050; 
Aviva Systems, 1/1000e), rabbit anti-Kif2A (ab37005; Abcam,1/5000e), mouse anti-
Aurora A (ab13824; Abcam, 1/1000e), rabbit anti-Dda3 (GTX128047; GeneTex, 
1/1000e), rabbit anti-GFP (6556; Abcam, 1/1000e), mouse anti-GFP (ab1218; 
Abcam, 1/1000e), mouse anti-alpha-tubulin (T9026; Abcam, 1/5000e), anti-
phospho-histone H3 (06-570; Millipore, 1/1000e), mouse anti-gamma-actin 
(ab123034; Abcam, 1/5000e), mouse anti-vinculin (V9264; Sigma, 1/5000e). 
 
Immunoprecipitations 
HeLa or MCF-7 cells were transfected as described above and lysed in lysis buffer 
containing 50mM Tris-HCl pH 7.4, 150mM NaCl, 1mM EDTA, 2.5mM MgCl2, 0.2M 
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PMSF, 1mM Aprotinin, 5mg/ml Leupeptin, 2mg/ml Pepstatin, 0.2M orthovanadate, 
1M sodium fluoride, and 10µM okadaic acid. Lysates were centrifuged, incubated 
with uncoupled magnetic agarose beads at 4°C for 15 minutes, and then incubated 
with anti-GFP VHH coupled to magnetic agarose beads (GFP-trap_MA; Chromotek) 
at 4°C overnight. Antibody beads were recovered with a bar magnet, washed once 
with the lysis buffer in the presence of anti-proteases and then twice with the lysis 
buffer, and analyzed by Western blotting with appropriate antibodies as described 
above. Results shown are representative of 3 to 5 independent experiments.  
 
Proteomics and Mass spectrometry 
MCF-7 cells were transfected with GFP-ATIP3 or GFP for 24h then lysed as 
described above. For immuno-isolated samples, 1 mg extract was incubated with 
25 μl magnetic beads (GFP-trap_MA; Chromotek) for 2 hours at 4°C. 
Proteins on magnetic beads were washed twice with 100 μl of 25 mM NH4HCO3 
and on-beads digestion were performed with 0.2 μg of trypsine/LysC (Promega) for 
1 hour in 100 µl of 25 mM NH4HCO3. Sample were then loaded onto a homemade 
C18 StageTips for desalting (principle by stacking one 3M Empore SPE Extraction 
Disk Octadecyl (C18) and beads from SepPak C18 CartridgeWaters into a 200 μl 
micropipette tip). Peptides were eluted using 40/60 MeCN/H2O + 0.1% formic acid 
and vacuum concentrated to dryness. 
Online chromatography was performed with an RSLCnano system (Ultimate 3000, 
Thermo Scientific) coupled online to an Orbitrap Fusion Tribrid mass spectrometer 
(Thermo Scientific). Peptides were trapped on a C18 column (75 μm inner diameter 
× 2 cm; nanoViper Acclaim PepMapTM 100, Thermo Scientific) with buffer A (2/98 
MeCN/H2O in 0.1% formic acid) at a flow rate of 4.0 µl/min over 4 min. Separation 
was performed on a 50 cm x 75 μm C18 column (nanoViper Acclaim PepMapTM 
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RSLC, 2 μm, 100Å, Thermo Scientific) regulated to a temperature of 55°C with a 
linear gradient of 2% to 30% buffer B (100% MeCN in 0.1% formic acid) at a flow 
rate of 350 nl/min over 160 min. Full-scan MS was acquired in the Orbitrap analyzer 
with a resolution set to 120,000 and ions from each full scan were HCD fragmented 
and analyzed in the linear ion trap. 
For identification the data were searched against the SwissProt Homo Sapiens 
(February 2017, no isoforms) database using Sequest HF through proteome 
discoverer (version 2.1). Enzyme specificity was set to trypsin and a maximum of 
two missed cleavage site were allowed. Oxidized methionine, N-terminal 
acetylation, and carbamidomethyl cysteine were set as variable modifications. 
Maximum allowed mass deviation was set to 10 ppm for monoisotopic precursor 
ions and 0.6 Da for MS/MS peaks. 
The resulting files were further processed using myProMS [31] v3.6 (work in 
progress). FDR calculation used Percolator and was set to 1% at the peptide level 
for the whole study. The label free quantification was performed by peptide 
Extracted Ion Chromatograms (XICs) computed with MassChroQ version 2.2.2 [32]. 
For protein quantification, XICs from proteotypic peptides shared between 
compared conditions (TopN matching) with no missed cleavages were used. 
Median and scale normalization was applied on the total signal to correct the XICs 
for each biological replicate. To estimate the significance of the change in protein 
abundance, a linear model (adjusted on peptides and biological replicates) was 
performed and p-values were adjusted with a Benjamini–Hochberg FDR procedure 
with a control threshold set to 0.05. Fold change-based GO enrichment analysis 
was performed as described [33]. 
The mass spectrometry proteomics data have been deposited to the 
ProteomeXchange Consortium via the PRIDE [34] partner repository with the 
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dataset identifier PXD009182 (username: reviewer03478@ebi.ac.uk, password: 
UFFpYuYZ). 
 
Immunofluorescence 
Cells were fixed on cover glasses with ice-cold methanol for 5 minutes and washed 
with PBS. Coverslips were subsequently incubated at room temperature for 1 hour 
in primary antibodies and for 1 hour in Alexa Fluor 488-, Alexa Fluor 549- and Alexa 
Fluor 647-coupled secondary antibodies diluted in PBS/Triton 0.1%, BSA 0.2%. The 
following primary antibodies were used: rabbit anti- Kif2A (ab37005; Abcam, 
1/250e), rabbit anti-pericentrin (ab4448; Abcam, 1/500e), rabbit anti-Dda3 
(GTX128047; GeneTex, 1/500e), mouse anti-Aurora A (ab13824; Abcam, 1/200e), 
rabbit Phospho-Aurora A (Thr288) (3079S; Cell Signaling, 1/200e), mouse anti-GFP 
(ab1218; Abcam, 1/250e), rat anti-alpha-tubulin (ab6160; Abcam, 1/500e), mouse 
anti-gamma-tubulin (T5326; Sigma, 1/500e) and mouse anti-alpha- tubulin (T9026; 
Sigma, 1/100e). Coverslips were fixed with Glycergel Mouting Medium (Dako) 
coupled with DAPI. Images were acquired with a confocal laser scanning 
microscope Dmi8- SP8 with an HC PL APO CS2 40x-1.3 Oil (Leica). Linescan 
analyses of pole-to-pole distance and fluorescence intensities were done with Image 
J. At least 30 cells in 4 to 10 fields per condition were analyzed. 
Results shown are representative of 3 to 5 independent experiments.  
 
Fluorescence Recovery After Photobleaching (FRAP) 
HeLa cells were transfected with control or ATIP3 siRNA and co-transfected with 
Kif2A-GFP. For the experiment, cells were seeded in 35 mm glass-bottomed dishes 
(14mm, No. 1.5, MatTek Corporation). The siRNA transfection was done 72 hours 
prior to filming using Lipofectamine 2000 (Invitrogen). Kif2A-GFP was co-
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transfected 48 hours after siRNA transfection. 10nM SiR-DNA (Spirochrome) was 
added to the cell culture medium 30 minutes before starting the live-cell imaging. 
Time-lapse imaging was performed at 37ºC using a Plan-Apochromat 63x/1.4NA 
with differential interference contrast oil objective mounted on an inverted Zeiss Axio 
Observer Z1 microscope (Marianas Imaging Workstation from Intelligent Imaging 
and Innovations Inc. (3i), Denver, CO, USA), equipped with a CSU-X1 spinning-disk 
confocal head (Yokogawa Corporation of America). Images were acquired using an 
iXon Ultra 888 EM-CCD camera (Andor Technology). After identification of spindle 
poles in metaphase cells, one of the two poles was photobleached with a 5ms laser 
pulse using 100% power of the 488nm solid state laser, and the fluorescence 
recovery was recorded for 90 seconds at 500 ms intervals. For FRAP calculations, 
the fluorescence intensity of the bleached area was normalized using the intensity 
of the whole cell, after background correction. Then a full-scale normalization was 
performed and the mean values were plotted and used for exponential curve fitting 
using GraphPad Prism 7.01 to determine the half-life and efficiency of the recovery. 
 
 
Poleward microtubule flux rate measurement 
Photo-conversion of alpha-tubulin was performed using a stable U2OS-mEOS- 
tubulin cell line [35] cultivated on 35 mm glass-bottomed dishes (14mm, No. 1.5, 
MatTek Corporation). Transfection of control or ATIP3 siRNA was done 48h hours 
prior to filming using Lipofectamine 2000 (Invitrogen). Time-lapse imaging was 
performed at 37ºC using a Plan-Apochromat 63x/1.4NA oil objective with differential 
interference contrast mounted on an inverted Zeiss Axio Observer Z1 microscope 
(Marianas Imaging Workstation from Intelligent Imaging and Innovations Inc. (3i), 
Denver, CO, USA), equipped with a CSU-X1 spinning-disk confocal head 
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(Yokogawa Corporation of America) and a photo-activation system with 405 nm 
laser line. Images were acquired using an iXon Ultra 888 EM-CCD camera (Andor 
Technology). Late prometaphase/metaphase cells were identified upon green 
fluorescent tubulin signals and two line-shaped regions of interest were placed 
perpendicular to the main spindle axis on both sides of the metaphase plate in order 
to be photo-activated. Photo-conversion was performed by a 5-ms 405-nm laser 
pulse. Photo-converted red signals were then followed over time together with green 
fluorescence signal using 561- and 488-nm lasers and images were acquired every 
5 s for 3 min. Microtubule flux was quantified by tracking photo- converted mEos-
tubulin over time using sum-projected kymographs generated by a MATLAB-based 
algorithm [36]. 
 
Statistical analysis 
Statistical analyses were done using GraphPad Prism 6.0 software. Data in bar 
graphs (mean +/- SD) and dot plots were analyzed using two-tail unpaired t-test and 
ANOVA test. p<0.05 was considered statistically significant. 
  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
12 
 
 
RESULTS 
 
ATIP3 depletion reduces metaphase spindle length  
To evaluate the consequences of ATIP3 depletion in mitosis, HeLa cells were 
transfected with two independent ATIP3 siRNAs (siA#1 and siA#2) (Fig. 1A) and 
mitotic cells were analyzed by immunofluorescence. By measuring pole-to-pole 
distance in metaphase cells using pericentrin as a marker, we observed that ATIP3 
depletion with each siRNA reduces spindle length (Fig. 1B). Similar results were 
obtained using both ATIP3 siRNAs in HCC1143 breast cancer cells (Fig. S1A). 
Conversely, moderate expression of GFP-ATIP3 in ATIP3-negative MCF-7 cells led 
to an increase in spindle size compared to control cells expressing GFP (Fig. S1B).  
Other mitotic defects such as multipolar spindles (Fig. S1C) and spindle 
mispositioning (Fig. S1D) were observed in ATIP3-depleted cells but spindle 
orientation, symmetry and cell size remained unchanged (Fig. S1E). 
 
ATIP3 interacts with Kif2A  
In a first step to elucidate the molecular mechanisms by which ATIP3 controls 
spindle size, we undertook a proteomic approach to identify novel intracellular 
ATIP3 binding partners. Anti-GFP antibodies were used to immunoprecipitate 
molecular complexes from MCF-7 breast cancer cells expressing either GFP or 
GFP-ATIP3 fusion protein. Mass spectrometry analysis allowed us to identify 145 
proteins that selectively interact with ATIP3 (Table S1), nine of which were related 
to the microtubule cytoskeleton and/or mitosis (Fig. 1C, Table 1). These include 3 
tubulin chains (beta6, alpha4 and beta3), 2 centromere/kinetochore associated 
proteins (CENPB, CHAMP1) and 4 centrosomal/spindle pole proteins (SDCCAG8, 
TBBCD1, PCM1 and Kif2A). The Kif2A kinesin was among the best candidate 
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ATIP3 partners in terms of fold change (4.86) and p value (8.14e-22). This 
depolymerizing kinesin is also a well-known regulator of mitotic spindle length [10] 
and was therefore selected for further studies. 
The interaction between ATIP3 and Kif2A was confirmed by co-immunoprecipitation 
analyses. GFP-ATIP3 fusion protein expressed in MCF-7 cells was 
immunoprecipitated using anti-GFP antibodies and found to bind endogenous Kif2A 
(Fig. 1D). Kinesin Kif2B was not retained in GFP-ATIP3 immunocomplexes, 
indicating specificity. Conversely, endogenous ATIP3 was found to interact with 
Kif2A-GFP in HeLa cells (Fig. 1E), confirming the existence of ATIP3-Kif2A 
molecular complexes. As shown in Fig. S1F, ATIP3 not only interacts, but also co-
localizes with Kif2A at the spindle poles in metaphase. 
To better characterize the interaction, full-length ATIP3 was cleaved into three 
regions designated D1, D2 and D3 (Fig. 1F) that were fused to GFP. After transient 
transfection of GFP-tagged constructs followed by co-immunoprecipitation, results 
showed that a central region of 410 amino-acids (D2 region) interacts with Kif2A 
(Fig. 1F, right panel). Deletion mutants of the D2 region were then analyzed. A 
sequence (D2C) encompassing amino acid residues 705-874 of ATIP3 was 
sufficient to bind Kif2A (Fig. 1G, left panel). Deletion of amino acids 705-816 (GFP-
delCN) and 635-816 (GFP-delCN2) in the ATIP3 sequence led to a marked 
decrease in Kif2A interaction (Fig. 1G, right panel). Deleting the same sequences 
from the D2 polypeptide also impaired the interaction (Fig. S2A), therefore indicating 
that a minimal sequence of 112 amino acids (CN sequence) is required for ATIP3 
interaction with Kif2A. 
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ATIP3-Kif2A complex controls metaphase spindle length 
To investigate the functional impact of ATIP3-Kif2A complex in the control of mitotic 
spindle length, we investigated whether GFP-ATIP3 construct and deletion mutants 
were able to rescue the ATIP3 depletion phenotype. RNAi-resistant GFP-ATIP3 
expressed at moderate levels in ATIP3-depleted cells indeed restored a spindle size 
similar to that observed in control cells (Fig. 2A). In contrast, deletion mutants GFP-
DelCN and GFP-DelCN2 - that are unable to interact with Kif2A - failed to rescue 
the phenotype (Fig. 2A, S2B). Furthermore, expressing the Kif2A-interacting region 
D2 was sufficient to restore a correct spindle length in ATIP3-depleted cells whereas 
Kif2A-binding defective mutants D2delCN and D2delCN2 were not (Fig. S2C). 
Together these data strongly suggest that ATIP3 may control metaphase spindle 
size by interacting with Kif2A. 
 
ATIP3 depletion increases Kif2A targeting to the spindle poles 
Immunofluorescence studies revealed that ATIP3 depletion markedly increases 
Kif2A fluorescence intensity at spindle poles (Fig. 2B) with no effect on the cytosolic 
pool of Kif2A (Fig. S2D). In contrast, ATIP3 depletion did not significantly modify 
fluorescence intensity of pericentrin, a major spindle pole protein (Fig. S2E). 
Expression of RNAi-resistant GFP-ATIP3 in ATIP3-depleted cells rescued the 
phenotype and decreased Kif2A intensity at the poles (Fig. 2C). Of note, ATIP3 
silencing had no effect on total Kif2A protein levels detected by western blotting (Fig. 
2B, left panel), suggesting that increased fluorescence intensity of Kif2A may reflect 
increased recruitment to the poles rather than increased expression of the protein.  
We then evaluated whether increased Kif2A accumulation at spindle poles may 
contribute to the phenotype of ATIP3 deficiency. Silencing of Kif2A in ATIP3-
depleted cells (Fig. S2F) indeed rescued the phenotype and restored a correct 
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spindle size (Fig. 2D), indicating that increased Kif2A recruitment to the poles is 
responsible for spindle length shortening in ATIP3-depleted cells.  
It has been previously shown that Kif2A regulates metaphase spindle length by 
controlling poleward microtubule flux via its microtubule depolymerizing activity at 
the spindle poles [6, 10, 11]. We reasoned that by increasing Kif2A depolymerizing 
activity at the poles, ATIP3 deficiency may disrupt the balance of microtubule 
dynamics in the spindle, resulting in decreased poleward flux and shorter spindle 
length. To address that question, microtubule flux rates were analyzed following 
ATIP3 silencing in metaphase U2OS cells stably expressing alpha-tubulin fused to 
the photo-convertible fluorescent protein mEos2 [35]. Results indicate that poleward 
microtubule flux is significantly decreased in ATIP3-depleted cells (0.53±0.13 
µm/min) compared to control cells (0.67±0.08 µm/min, p<0.0001) (Fig. 2E), 
supporting the notion that ATIP3 may control spindle size by regulating the 
recruitment - and thus, depolymerizing activity - of Kif2A to the poles. Collectively, 
these data indicate that ATIP3 controls metaphase spindle length by interacting with 
the Kif2A kinesin and reducing its recruitment to the poles. 
 
ATIP3-Kif2A interaction involves Dda3 
How does ATIP3 silencing increase Kif2A targeting at the spindle poles? We 
hypothesized that ATIP3 may sequester Kif2A in the cytosol and slower the 
exchange rate between spindle pole-associated Kif2A and a diffuse cytosolic pool 
of the protein. We thus explored the dynamic behavior of Kif2A turnover on spindle 
poles in the presence or absence of ATIP3. Fluorescence recovery after 
photobleaching (FRAP) experiments were performed on metaphase HeLa cells 
expressing endogenous ATIP3 and transfected with Kif2A-GFP. Bleaching was 
done on one of the two spindle poles. We found that in control cells, Kif2A-GFP 
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association with spindle poles is dynamic. Ninety percent of the signal was 
recovered after photobleaching, with a half-recovery time of 11.6 sec (Fig. 3A) which 
is faster than that (30.7 sec) reported for NuMA, another major spindle pole-
associated protein [37]. In ATIP3-depleted cells, Kif2A-GFP fluorescence recovery 
parameters remained unchanged (half-recovery time of 11.62 sec), ruling out the 
hypothesis that ATIP3 depletion may regulate Kif2A turnover at the spindle poles. 
We then investigated whether ATIP3 may regulate Kif2A localization by a 
mechanism involving Dda3, a microtubule-associated protein known to interact with 
and increase Kif2A targeting to spindle poles [17]. As shown in Fig. 3B, Dda3 
silencing in ATIP3-depleted cells rescued Kif2A fluorescence intensity at spindle 
poles, indicating that Dda3 contributes to the regulatory effects of ATIP3 on Kif2A 
recruitment. Accordingly, Dda3 silencing also restored a correct spindle length in 
ATIP3-depleted cells (Fig. 3B), indicating that Dda3 is essential to the ATIP3 
phenotype. Immunofluorescence analyses revealed that, as for Kif2A, Dda3 fluorescence 
intensity at the poles is increased upon ATIP3 depletion (Fig. 3C). Conversely, expression 
of GFP-ATIP3 led a decrease of Dda3 recruitment to the poles compared with GFP (Fig. 
3D). Of note, silencing of either Kif2A or Dda3 had no significant effect on ATIP3 
fluorescence intensity (Fig. S3), pointing to ATIP3 as an upstream regulator of Kif2A and 
Dda3 targeting to the poles. 
Dda3 is a known partner of Kif2A, raising the possibility that it may be part of the 
ATIP3-Kif2A complex. Immunoprecipitation studies revealed that Dda3 indeed 
interacts with ATIP3 (Fig. 3E). To evaluate whether Dda3 may compete with, or 
contribute to, ATIP3-Kif2A interaction, Dda3 was silenced using siRNA prior to 
immunoprecipitation with GFP-ATIP3. Results showed that Dda3 depletion impaired 
Kif2A binding to GFP-ATIP3 immunocomplexes (Fig. 3F) indicating that Dda3 is 
required for ATIP3-Kif2A interaction.  
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The interaction between ATIP3, Kif2A and Dda3 is regulated in mitosis 
Dda3 levels have been shown to be elevated in mitosis [17] leading us to investigate 
whether ATIP3-Dda3 interaction may also be regulated in mitosis. Co- 
immunoprecipitation studies performed in synchronized MCF-7 cells expressing 
GFP-ATIP3 indeed revealed that the interaction between ATIP3 and Dda3 is 
increased in mitosis (Fig. 3G). Importantly, Kif2A binding to GFP-ATIP3 was also 
markedly increased in synchronized cells although Kif2A levels remained 
unchanged (Fig. 3G), which further supports the notion that Dda3 is essential to the 
ATIP3-Kif2A complex. Data showing Dda3 hyperphosphorylation in mitosis [38] 
prompted us to examine whether the interaction between ATIP3, Dda3 and Kif2A 
may be regulated by phosphorylation. Treatment with lambda phosphatase prior to 
immunoprecipitation with GFP-ATIP3 totally abrogated both Dda3- and Kif2A-
binding to GFP-ATIP3 (Fig. S4A), indicating that protein phosphorylation is required 
for ATIP3-Dda3-Kif2A interaction. 
 
Aurora kinase A plays a pivotal role in the ATIP3 phenotype 
Mitosis is tightly regulated by mitotic kinases among which Aurora kinase A (Aurora 
A), that is localized to the poles of the spindle and whose expression is markedly 
increased in G2/M. Aurora A has been shown to phosphorylate both Dda3 [18, 38] 
and Kif2A [19] and to decrease the recruitment and microtubule-depolymerizing 
activity of Kif2A at the spindle poles [19]. We thus investigated whether Aurora A 
may be a master kinase regulating ATIP3-Dda3-Kif2A interaction. 
Treatment with Aurora A kinase inhibitor MLN8054 impaired both ATIP3-Kif2A and 
ATIP3-Dda3 interactions (Fig. 4A), indicating that Aurora A kinase activity is 
required for ATIP3 interaction with Kif2a and Dda3. Aurora A depletion by siRNA 
also markedly decreased ATIP3-Kif2A interaction (Fig. S4B). Co-
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immunoprecipitation studies revealed that Aurora A binds to GFP-ATIP3 (Fig. S4C). 
Of note, ATIP3/Aurora A complexes were not always clearly detectable, suggesting 
that this interaction may be weak and/or transient.  
In addition to disrupting the interaction of ATIP3 with Kif2A and Dda3, Aurora A 
inactivation by silencing or pharmacological inhibition mimics the phenotype of 
ATIP3 depletion regarding Kif2A recruitment to the pole and regulation of spindle 
size (Fig. S4D, S4E). This led us to investigate whether Aurora A itself may be 
regulated by ATIP3. Immunofluorescence analyses revealed that ATIP3 silencing 
decreases Aurora A fluorescence intensity at spindle microtubules and poles (Fig. 
4B, S4F), with no significant change in total protein levels detected by western blot 
(Fig. 4B). Fluorescence intensity of the phosphorylated (Thr288) active form of the 
kinase was also reduced upon ATIP3 depletion (Fig. 4B), suggesting that ATIP3 
contributes to maintaining an active pool of Aurora A at the poles of the mitotic 
spindle. We thus examined the possibility that Aurora kinase A activity may be 
involved in the ATIP3 phenotype. To investigate whether the short spindle 
phenotype induced by ATIP3 depletion may be due to decreased Aurora A kinase 
activity at the poles, we ectopically expressed a GFP-Aurora A construct (GFP-
AurA), or kinase-dead mutant (GFP-AurA-KD) in ATIP3-silenced cells and analyzed 
mitotic cells. As shown in Fig. 4C, active GFP-AurA expressed at moderate levels 
in ATIP3 deficient cells was able to restore a correct mitotic spindle size whereas 
the kinase dead GFP-AurA-KD mutant remained inefficient. Expression of GFP-
AurA construct, but not the kinase dead GFP-AurA-KD mutant, also reverted the 
effects of ATIP3 silencing on Kif2A fluorescence intensities at the poles (Fig. 4D). 
Together, these results demonstrate that Aurora A kinase activity rescues mitotic 
spindle defects induced by ATIP3 deficiency, and highlight the central role of Aurora 
A in the control of metaphase spindle length by ATIP3.  
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DISCUSSION 
Tight control of mitotic spindle length during metaphase is essential to ensure 
correct cell division. Results presented here indicate that microtubule-associated 
protein ATIP3 controls metaphase spindle length by interacting with the microtubule 
depolymerizing kinesin Kif2A to negatively regulate its association with spindle 
poles. ATIP3 depletion causes increased Kif2A targeting to the poles, reduced 
poleward microtubule flux and shorter spindle size. Increased accumulation of Kif2A 
on spindle poles, and subsequent excessive depolymerization of spindle 
microtubule minus ends, may disrupt the balance between microtubule 
polymerization at kinetochores and depolymerization at spindle poles in metaphase. 
Imbalanced dynamics of spindle microtubules may account for reduced poleward 
microtubule flux and short spindle observed upon ATIP3 depletion. 
We show here by fluorescence recovery after photobleaching (FRAP) analyses that 
the binding of Kif2A on spindle poles is dynamic. Cytosolic pools of GFP-Kif2A were 
found to exchange in and out of spindle poles with half-recovery time around ten 
seconds, which is a little faster than for other spindle pole-associated proteins such 
as NuMA [37]. Of note, ATIP3 silencing has no significant effect on Kif2A turnover 
at the poles, making unlikely the possibility that ATIP3 may sequester Kif2A in the 
cytosol as a mechanism to limit its targeting to spindle poles. The effect of ATIP3 
rather involves Dda3, a microtubule-associated protein that binds Kif2A and 
facilitates its recruitment to the poles [17]. As for Kif2A, ATIP3 depletion increases 
Dda3 accumulation on the poles. Dda3 silencing in ATIP3-deficient cells rescues 
the phenotype and restores basal levels of Kif2A fluorescence intensity on the poles 
as well as correct size of the spindle. These findings strongly suggest that Dda3 
contributes to ATIP3 effects on spindle length by regulating Kif2A recruitment to the 
poles. While ATIP3 regulates both Kif2a and Dda3 targeting to the poles, silencing 
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of either Kif2A or Dda3 has no effect on ATIP3 localization, suggesting that ATIP3 
is upstream of Kif2A/Dda3 and orchestrates the targeting of both proteins to the 
poles to control spindle length. 
ATIP3 interacts with Kif2A and Dda3 in a molecular complex that is increased in 
mitosis and requires phosphorylation by the mitotic kinase Aurora A. In return, 
ATIP3 is necessary to maintain an active pool of Aurora A at spindle poles, indicating 
a positive regulatory loop between Aurora A and ATIP3.  
In the absence of ATIP3, Aurora A levels at spindle poles are decreased whereas 
those of Kif2A and Dda3 are increased. Expression of GFP-Aurora A kinase - but 
not a kinase-dead mutant - in ATIP3-depleted cells restored basal levels of Kif2A 
localized at the poles as well as a correct spindle size, confirming the requirement 
of Aurora kinase activity in the mitotic effects of ATIP3. Together these studies favor 
a model by which ATIP3 regulates the localization of active Aurora kinase A during 
mitosis to limit Kif2A recruitment to the poles and control spindle length. 
The negative regulation of Kif2A accumulation at spindle poles during metaphase is 
essential to prevent excessive depolymerization of microtubule minus ends that may 
lead to mitotic abnormalities. Besides ATIP3, other negative regulators of the 
Dda3/Kif2A complex have been reported. Mdp3 (microtubule-associated protein 7 
domain-containing 3) forms a complex with Dda3 and Kif2A in mitosis and 
counteracts Dda3-mediated Kif2A recruitment to the pole [39]. Another Dda3 
partner, the E3 ubiquitin ligase ASB7 (Cullin 5–interacting suppressor of cytokine 
signaling box 7) was shown to degrade Dda3 through the ubiquitin-proteasome 
degradation pathway, thereby reducing Kif2A recruitment to the pole [40]. Our data 
reveal a novel mechanism for negative regulation of Kif2A/Dda3 complex 
recruitment to the poles, which involves Aurora kinase A and its reciprocal regulation 
with ATIP3. Of note, ATIP3 weakly interacts with Aurora A and its amino acid 
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sequence presents several potential Aurora A phosphorylation sites, raising the 
possibility that ATIP3 may also be a substrate of Aurora A. TPX2, a well-known 
substrate and regulator of Aurora A, also interacts with Kif2A [13] and TPX2 
phosphorylation by Aurora A contributes to the regulation of poleward microtubule 
flux and spindle size [13, 22]. Future studies should investigate potential 
involvement of TPX2 in the ATIP3 phenotype. 
In conclusion, results presented here provide the first evidence for the role of Aurora 
kinase A in the formation of a molecular complex comprising ATIP3, Kif2A and 
Dda3, highlighting the pivotal role of ATIP3 and Aurora A kinase cross-regulation on 
spindle length. This study extends our knowledge on the control of the mitotic 
spindle size in metaphase.  
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Legend to Figure 1: ATIP3 interacts with Kif2A 
A. Immunoblotting with anti-ATIP3 (MTUS1) antibodies shows silencing efficiency 
of two different ATIP3-specific siRNAs (siA#1 and siA#2) transfected in HeLa cells. 
Blots were reprobed with anti-vinculin antibodies for internal control. 
B. Immunofluorescence imaging of HeLa cells transfected with control (siC), and 
two different ATIP3-specific siRNAs (siA#1 and siA#2) as indicated. Cells were 
stained with anti-pericentrin (red), anti-alpha-tubulin (gray) antibodies and DAPI 
(blue). Scale bar, 10 µm. Pole-to pole distance (white arrow) was measured by 
drawing a line with ImageJ software between the two poles stained with pericentrin. 
Right panel shows quantification of spindle length in metaphase. Number of cells 
analyzed is under brackets. ***p<0.001. 
C. Volcano plot showing distribution of the 9 proteins related to the microtubule 
cytoskeleton and/or mitosis present in GFP-ATIP3 compared with GFP and 
identified by mass spectrometry. x axis = log2(fold-change), y axis = - log10(p-
value). Position of the ATIP3 partner Kif2A is indicated in red. 
D. MCF-7 cells were transfected with GFP-ATIP3 or GFP and immunoprecipitation 
was performed using anti-GFP antibodies. Western blots were probed with anti-
Kif2A, anti-Kif2B and anti-GFP antibodies to reveal Kif2A, Kif2B, GFP-ATIP3 and 
GFP. A red asterisk indicates a non-specific band. 
E. HeLa cells were transfected with Kif2A-GFP or GFP and immunoprecipitation 
was performed using anti-GFP antibodies. Western blots were probed with anti-
ATIP3 (MTUS1) and anti-GFP antibodies to reveal ATIP3, Kif2A-GFP and GFP. 
F. Schematic representation of the ATIP3 protein sequence illustrating the position 
of D1, D2 and D3 regions and ATIP3 deletion mutants, and their ability (+) or not (-
) to bind Kif2A. Kif2A-binding regions are in red. CC: coiled coil region. Amino acid 
numbering is from accession number NP_001001924. Right panel: 
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immunoprecipitation assay of MCF-7 cell lysates expressing GFP, GFP-ATIP3 or 
GFP-fused D1, D2, D3 regions. Blots were probed with anti-Kif2A and anti-GFP 
antibodies. A red asterisk indicates non-specific band corresponding to cleavage 
product of GFP-D2. A black asterisk indicates the position of GFP-D1 at the same 
size as endogenous Kif2A revealed in previous blotting. 
G. MCF-7 cells were transfected with GFP-D2 fragments (left panel) or GFP-ATIP3 
deletion mutants (right panel) and immunoprecipitation was performed using anti-
GFP antibodies. Blots were probed as in F. Red asterisk indicates a non-specific 
band.  
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Legend to Figure 2: ATIP3 regulates Kif2A recruitment to spindle poles 
A. Immunofluorescence imaging of HeLa cells transfected for 48h with control (siC) 
or ATIP3-specific (siA) siRNA as indicated, then for 24h with GFP, GFP-ATIP3, or 
ATIP3 deletion mutants (GFP-delCN and GFP-delCN2) as indicated. Cells were 
stained with anti-GFP (green) and anti-pericentrin (red) antibodies and DAPI (blue). 
Scale bar, 10µm. Spindle length was measured as in Figure 1B. Right panel shows 
quantification of spindle length in metaphase HeLa cells. Number of cells analyzed 
is under brackets.  ***p<0.001, ns: not significant. 
B. Left panel: Immunoblotting of HeLa cell lysates following transfection with control 
(siC) or ATIP3-specific (siA) siRNA as indicated. Blots were probed with anti-MTUS1 
(ATIP3), anti-Kif2A and anti-tubulin antibodies. Middle panel: Immunofluorescence 
imaging of HeLa cells transfected with control (siC) or ATIP3- specific (siA) siRNA 
as indicated. Cells were fixed and stained with anti-Kif2A (green) antibodies and 
DAPI (blue). Scale bar, 10µm. Kif2A fluorescence intensity was measured by 
drawing a line with ImageJ software between the two poles and the maximum 
intensity values at the poles were collected and normalized to the intensity of 
gamma-tubulin. Right panel: Quantification of Kif2A intensity in metaphase HeLa 
cells. Number of poles analyzed is under brackets. ***p<0.001. 
C. Immunofluorescence imaging of Hela cells transfected with control or ATIP3-
specific siRNA for 48h, then were transfected for 24h with GFP or GFP-ATIP3, fixed 
and stained with anti-Kif2A (red) and anti-GFP (green) antibodies and DAPI (blue). 
Scale bar, 10 µm. Right panel shows quantifications of Kif2A intensity at poles in 
metaphase HeLa cells. Number of poles analyzed is under brackets. ***p<0.001. 
D. Immunofluorescence imaging of HeLa cells transfected with control (siC), ATIP3-
specific (siA) and/or Kif2A-specific (siK) siRNA as indicated, and stained as in (B). 
Scale bar, 10µm. Middle panel: Spindle length (pole-to-pole distance) was 
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measured as in Figure 1B. Number of metaphase cells analyzed is under brackets. 
Right panel: Quantification of Kif2A intensity in metaphase HeLa cells as in 2B. 
Number of poles analyzed is under brackets. *p<0.05, **p<0.01, ***p<0.001. 
E. Upper left panel: Representative fluorescence images of U2OS-mEOS-tubulin 
cells in late prometaphase/metaphase transfected with control (siC) and ATIP3 (siA) 
siRNAs. Images were captured before (pre) and after photo-conversion of mEOS-
tubulin. Microtubule flux was measured by photoconversion of line-like regions from 
both half-spindles in mEos-tubulin cells and tracking of photoconverted mEOS-
tubulin over a time interval of 3 min. Scale bar, 10 μm; time, min:sec. Lower left 
panel: Representative sum-projected kymographs of photoactivated regions used 
for quantification of flux rates in control (siC) and ATIP3-depleted (siA) cells. Red 
dashed line indicates the slope of mEOS tubulin translocation over time. Scale bar, 
30 sec. Upper right panel: Quantification of microtubule flux in control versus ATIP3-
depleted cells. Number of cells analyzed is under brackets. ***p<0.001. Lower right 
panel: Immunoblotting-based validation of ATIP3 siRNA efficiency. 
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Legend to Figure 3: ATIP3-Kif2A interaction involves Dda3 
A. Left panel: Representative spinning-disk confocal live-cell images of HeLa cells 
in metaphase, expressing Kif2A-GFP and co-stained with SiR-DNA. Red circle 
indicates the bleaching area used for fluorescence recovery after photobleaching 
(FRAP). Scale bar, 5 µm. Time shown in seconds. Right panel: FRAP data points 
represent means obtained from 28 control cells (siC) and 21 siATIP3-transfected 
cells (siA), collected from 3 independent experiments. The mean values of double 
normalized pixel intensities were plotted as a function of time and single exponential 
curves were fitted (R2>0.99). Kif2A-GFP fluorescence was recovered to 89% in 
control cells and to 86% in siATIP3-transfected cells. The half-lives of Kif2A-GFP 
fluorescence recovery were calculated for control (11.62 s) and siATIP3-transfected 
cells (11.6 s). Error bars represent standard deviation. Representative 
immunoblotting data obtained from the indicated total cell extracts used in FRAP 
experiment is shown below the curves. 
B. Left panel: HeLa cells were transfected with control (siC), ATIP3-specific (siA) 
and/or Dda3-specific (siD) siRNA as indicated and analyzed by immunoblotting with 
anti-MTUS1 (ATIP3), anti-Kif2A and anti-Dda3 antibodies. Middle panel: 
Immunofluorescence imaging of HeLa cells transfected as in left panel, then fixed 
and stained with anti-Kif2A (green) antibodies and DAPI (blue). Scale bar, 10µm. 
Right panel: Quantification of Kif2A fluorescence intensity at the poles as in Figure 
2B and quantification of spindle length as in Figure 1B. Number of poles (for Kif2A 
staining) and cells (for spindle measurement) analyzed is under brackets. **p<0.01, 
***p<0.001. 
C. Immunofluorescence imaging of HeLa cells transfected with control (siC) or 
ATIP3-specific (siA) siRNA, then fixed and stained with anti-Dda3 antibodies 
(magenta) and DAPI (blue). Scale bar, 10µm. Dda3 fluorescence intensity at the 
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poles was measured using ImageJ software. Lower panel: Quantification of maximal 
Dda3 intensity in metaphase HeLa cells. Number of poles analyzed is under 
brackets. ***p<0.001. 
D. Immunofluorescence imaging of MCF-7 cells stably expressing GFP or GFP-
ATIP3 as indicated. Cells were fixed and stained with anti-GFP (green), anti-Dda3 
(magenta) antibodies and DAPI (blue). Scale bar, 10µm. Lower panel: Dda3 
fluorescence intensity at the poles was analyzed and quantified as in (C). Number 
of poles analyzed is under brackets. *p<0.05.  
E. MCF-7 cells were transfected with GFP-ATIP3 or GFP and immunoprecipitation 
was performed using anti-GFP magnetic beads. Western blots were probed with 
anti-Dda3 and anti-GFP antibodies 
F. MCF-7 cells were transfected for 24h with GFP-ATIP3 or GFP after transfection 
for 48h with control (siC), Kif2A-specific (siK) or Dda3-specific (siD) siRNA, and 
immunoprecipitation was performed using anti-GFP magnetic beads. Western blots 
were probed with anti-Kif2A, anti-Dda3 and anti-GFP antibodies. A red asterisk 
indicates a non-specific band. 
G. MCF-7 cells were transfected with GFP-ATIP3 or GFP and left asynchronous 
(AS) or synchronized in mitosis (M). Immunoprecipitation was performed using anti-
GFP antibodies. Blots were probed with anti-Dda3, anti-Kif2A, anti-GFP and anti-
PhosphoH3 antibodies. Red asterisks indicate cleavage products of GFP-ATIP3. 
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Legend to Figure 4: Aurora kinase A plays a pivotal role in the ATIP3 phenotype 
A. MCF-7 cells were transfected with GFP-ATIP3 or GFP, then treated with 500nM 
MLN8054 (MLN) (s1100, Selleckchem) or vehicle (NT) for 30 minutes at 37°C, and 
immunoprecipitation was performed using anti-GFP antibodies. Blots were probed 
with anti-GFP antibodies and anti-Kif2A (left panel) or anti-Dda3 (right panel) 
antibodies. A red asterisk indicates a non-specific band. 
B. Left panel: HeLa cells were transfected with control (siC) or ATIP3-specific (siA) 
siRNA as indicated. Immunoblotting was performed using anti-MTUS1 (ATIP3), anti-
Aurora kinase A (AurA) and anti-tubulin antibodies, and indicates that ATIP3-
silencing does not modify total expression levels of Aurora A. Middle panel: cells 
were fixed and stained with anti-Aurora A (AurA, red), anti-phospho-Aurora A (P-
AurA, green) antibodies and DAPI (blue). Scale bar, 10µm. Right panels: 
Quantification of the area occupied by total Aurora A fluorescence on spindles and 
poles, measured with ImageJ software. Phospho-Aurora A maximal fluorescence 
intensity at the poles was measured and quantified as in 2B. Number of poles 
analyzed is under brackets. ***p<0.001. 
C. Immunofluorescence imaging of HeLa cells transfected with control (siC) or 
ATIP3- specific (siA) siRNA for 48h and then with GFP, GFP-AurA or GFP-AurA-KD 
constructs for 24h as indicated. Cells were fixed and stained with anti-GFP (green), 
anti-pericentrin (red) antibodies and DAPI (blue). Note that all GFP-fusion constructs 
are expressed at similar levels. Right panel: Quantification of pole-to-pole distance. 
Number of cells analyzed is under brackets. *p<0.05, ***p<0.001. 
D. Immunofluorescence imaging of HeLa cells transfected as in 4C, then fixed and 
stained with anti-Kif2A (red) antibody and DAPI (blue). Right panel: Quantification 
of Kif2A intensity at poles. Number of poles analyzed is under brackets. **p<0.01, 
***p<0.001, ns: not significant. 
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Table 1: ATIP3 interacting partners related to microtubule cytoskeleton and/or mitosis 
MCF-7 cells were transfected with GFP or GFP-ATIP3 and cell lysates were precipitated using GFP-trap 
magnetic agarose beads. Proteins retained in immunocomplexes were analyzed by quantitative label-free 
mass spectrometry analysis performed on four replicates. Shown are the fold changes of 9 proteins 
related to microtubules and/or mitosis that were selected among 145 proteins quantified by label-free 
quantitative analysis of GFP-ATIP3 versus GFP according to absolute fold change ≥ 2, adjusted p-value 
of ratio significance ≤ 0.05 and more than 3 peptides. Proteins are listed by ratio order. 
 
Ratio Log2 p-value
MTUS1 400,563902 8,6458886 4,2716E-51 Microtubule-associated tumor suppressor 1
SDCCAG8 37,6347222 5,23399242 4,7636E-05 Serologically defined colon cancer antigen 8
TBCCD1 13,6959029 3,77567248 3,2558E-21 TBCC domain-containing protein 1
PCM1 4,92790341 2,30097398 6,9899E-19 Pericentriolar material 1 protein
KIF2A 4,86820741 2,28339063 8,1438E-22 Kinesin-like protein KIF2A
CENPB 3,58061441 1,84020717 1,35E-05 Major centromere autoantigen B
TUBB6 3,45212501 1,78748471 6,9563E-24 Tubulin beta-6 chain
TUBA4A 2,78607967 1,47823652 0,00032993 Tubulin alpha-4A chain
TUBB3 2,53211069 1,34034047 2,8227E-14 Tubulin beta-3 chain
CHAMP1 2,12271217 1,08590876 1,0626E-06 Chromosome alignment-maintaining phosphoprotein 1
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Figure 1 Click here to download Figure Nehlig et al, Fig 1.TIF 
Figure 2 Click here to download Figure Nehlig et al, Fig 2.TIF 
Figure 3 Click here to download Figure Nehlig et al, Fig 3.TIF 
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